Loading the security overview…
Where the tokens are
| Date | Direction | Gap | Previous close | Status | Sessions to fill | 20 sessions later |
|---|---|---|---|---|---|---|
| May 6, 2026 | Up | 10.3% | $135.06 | Open | — | +12.3% |
| Oct 29, 2025 | Down | 5.0% | $147.38 | Filled Nov 5, 2025 | 6 | +8.3% |
| May 6, 2025 | Up | 12.1% | $109.75 | Open | — | +1.2% |
| Feb 7, 2025 | Down | 16.3% | $150.51 | Open | — | −12.0% |
| Oct 30, 2024 | Up | 8.8% | $116.19 | Filled Nov 19, 2024 | 15 | +0.1% |
| Aug 28, 2024 | Down | 17.5% | $152.55 | Open | — | −7.9% |
| Aug 1, 2024 | Up | 6.1% | $141.57 | Filled Aug 28, 2024 | 20 | −14.5% |
| Apr 23, 2024 | Up | 5.5% | $133.66 | Filled May 29, 2024 | 26 | −0.3% |
| Feb 7, 2024 | Down | 5.6% | $142.96 | Filled Feb 7, 2024 | 1 | +0.2% |
| Nov 10, 2023 | Down | 5.2% | $112.15 | Filled Nov 14, 2023 | 3 | +11.5% |
| Sep 12, 2023 | Up | 5.5% | $109.64 | Filled Oct 3, 2023 | 16 | −1.2% |
| Feb 6, 2023 | Down | 5.2% | $110.03 | Filled Feb 6, 2023 | 1 | −5.7% |
| Nov 2, 2021 | Down | 8.2% | $106.22 | Open | — | −17.1% |
| Mar 25, 2021 | Up | 7.7% | $87.57 | Filled May 6, 2021 | 30 | +2.6% |
| Mar 2, 2021 | Down | 5.4% | $109.43 | Open | — | −8.9% |
| Nov 10, 2020 | Down | 12.3% | $102.81 | Filled Jan 7, 2021 | 40 | +1.9% |
| Mar 18, 2020 | Down | 6.3% | $79.61 | Filled Mar 19, 2020 | 2 | +27.7% |
| Mar 16, 2020 | Down | 8.3% | $85.34 | Filled Mar 16, 2020 | 1 | +22.8% |
| Mar 12, 2020 | Down | 6.3% | $85.90 | Filled Mar 13, 2020 | 2 | +20.2% |
| Mar 9, 2020 | Down | 7.0% | $93.06 | Filled Mar 26, 2020 | 14 | +5.5% |
Sessions are trading days. The change twenty sessions later is measured from the gap day’s open and is blank for gaps too recent to have one.
Figures describe Neurocrine Biosciences shares, not any token. From split-adjusted daily bars. How this stock's gaps behaved in the past, not a prediction of how the next one will.